Amgen, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 http://www.amgen.com 144.92 Stock Up +0.91

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Amgen, Inc.

9:01 am Amgen and Allergan (AGN) submit biosimilar marketing authorization application to European Medicines Agency for ABP 215, a biosimilar candidate to Bevacizumab - Dec 4th, 2016 7:01 am